VIRTUAL REALITY TECHNOLOGY FOR CEREBRAL PALSY

NCT ID: NCT05872217

Last Updated: 2023-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-30

Study Completion Date

2024-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The VRapeutic (Full-immersive game-based therapy) is new therapeutic Egyptian software. It has the potential to provide intensive, repetitive, and task-oriented training. It may increase children's motivation, enjoyment, active social participation. Children with UCP may experience varieties of associated health conditions as difficulty of movement, instability of postural balance, difficulty of motor planning and control which impact on UE function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ethical statement this study was approved by institutional Review Board of the faculty of physical therapy ,cairo university .Egypt (no.P.T.REC/012/004237) .

Study Design A prospective randomized controlled trial of pre-post study design with two months follow-up evaluation will be used.

Sample size estimation

will be conducted to determine the number of recruited children. G\*POWER statistical software (version 3.1.9.2) will be used using α=0.05, power 80% allocation ratio N2/N1 =1.

Randomization The selected children will be assigned by simple randomization via closed envelopes into two equal groups (control and study); the envelope will be contained a letter indicating whether the child will be assigned to the control or to the study group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

intervention Control Group: Children in this group will receive conventional UE therapeutic program for about 60 minutes/3session per week.

Children in this group will receive the same conventional UE therapeutic program as control group in addition to virtual reality session using fully-immersive VRapeutic software gaming technology (Archeeko module) for 30 min/3sessions/week for 8 weeks.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
A prospective randomized controlled trial of pre-post study design with two months follow-up evaluation will be used.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

• This group will receive conventional UE therapeutic program for 60 minutes each session including:

* Exercises based on neurodevelopment technique .
* Gentle manual stretching
* Weight-bearing exercises for 10minutes for UE from prone lying, side sitting and quadriped position .
* Strengthening exercises for 10 minutes for muscles of UE as push-up from prone lying position, quadriped position, 3 point exercise, walk on hand, climbing, hanging on a bar, squeeze stress balls, cutting usescissors to strengthen hand .
* Goal directed training for 10 minutes the child will practice specific tasks that are needed for everyday life and which they find a challenge like (3 daily tasks as cleaning mirror, dressing and undressing, using pen and ruler to draw shapes, brushing teeth .
* Fine motor activities as reach, grasp, carry and release activities.

Group Type PLACEBO_COMPARATOR

conventional upper extremity therapeutic program

Intervention Type OTHER

• This group will receive conventional UE therapeutic program for 60 minutes each session including:

* Exercises based on neurodevelopment technique .
* Gentle manual stretching for tight muscles of the affected UE from proximal to distal segments for 5minutes.
* Weight-bearing exercises for 10minutes for UE from prone lying, side sitting and quadriped position.
* Strengthening exercises for 10 minutes for muscles of UE as push-up from prone lying position, quadriped position, 3 point exercise, walk on hand, climbing, hanging on a bar, squeeze stress balls, cutting usescissors to strengthen hand .
* Goal directed training for 10 minutes the child will practice specific tasks that are needed for everyday life and which they find a challenge like (3 daily tasks as cleaning mirror, dressing and undressing, using pen and ruler to draw shapes, brushing teeth .
* Fine motor activities as reach, grasp, carry and release activities.

study group

Children in this group will receive the same conventional UE therapeutic program as control group for 60 minutes in addition to virtual reality session using VRapeutic software gaming technology, Archeeko module (figure 3) for 30 min/3 sessions/week for 8 weeks

Group Type EXPERIMENTAL

conventional upper extremity therapeutic program

Intervention Type OTHER

• This group will receive conventional UE therapeutic program for 60 minutes each session including:

* Exercises based on neurodevelopment technique .
* Gentle manual stretching for tight muscles of the affected UE from proximal to distal segments for 5minutes.
* Weight-bearing exercises for 10minutes for UE from prone lying, side sitting and quadriped position.
* Strengthening exercises for 10 minutes for muscles of UE as push-up from prone lying position, quadriped position, 3 point exercise, walk on hand, climbing, hanging on a bar, squeeze stress balls, cutting usescissors to strengthen hand .
* Goal directed training for 10 minutes the child will practice specific tasks that are needed for everyday life and which they find a challenge like (3 daily tasks as cleaning mirror, dressing and undressing, using pen and ruler to draw shapes, brushing teeth .
* Fine motor activities as reach, grasp, carry and release activities.

full immersive VRapeutic software gaming technology

Intervention Type OTHER

• Children in this group will receive the same conventional UE therapeutic program as control group for 60 minutes in addition to virtual reality session using VRapeutic software gaming technology, Archeeko module (figure 3) for 30 min/3 sessions/week for 8 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

conventional upper extremity therapeutic program

• This group will receive conventional UE therapeutic program for 60 minutes each session including:

* Exercises based on neurodevelopment technique .
* Gentle manual stretching for tight muscles of the affected UE from proximal to distal segments for 5minutes.
* Weight-bearing exercises for 10minutes for UE from prone lying, side sitting and quadriped position.
* Strengthening exercises for 10 minutes for muscles of UE as push-up from prone lying position, quadriped position, 3 point exercise, walk on hand, climbing, hanging on a bar, squeeze stress balls, cutting usescissors to strengthen hand .
* Goal directed training for 10 minutes the child will practice specific tasks that are needed for everyday life and which they find a challenge like (3 daily tasks as cleaning mirror, dressing and undressing, using pen and ruler to draw shapes, brushing teeth .
* Fine motor activities as reach, grasp, carry and release activities.

Intervention Type OTHER

full immersive VRapeutic software gaming technology

• Children in this group will receive the same conventional UE therapeutic program as control group for 60 minutes in addition to virtual reality session using VRapeutic software gaming technology, Archeeko module (figure 3) for 30 min/3 sessions/week for 8 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Their ages will range from of 6 to 10 years.

* Both genders will be included.
* Their degree of spasticity will range from 1 to 1+ according to the Modified Ashworth Scale (Meseguer et al., 2018).
* Their motor function will be at level I according to Gross Motor Function Classification System (Palisano et al., 2008).
* They will be able to understand and follow the instructions.

Exclusion Criteria

Children will be excluded from the study if they have any of the following criteria:

* Epilepsy.
* Visual or hearing problems.
* Musculoskeletal fixed deformity in upper limbs, lower limbs or spine.
* Orthopedic surgery on the involved UE.
* Botulinum toxin therapy for the affected UE within the past 6 months or within the study period.
Minimum Eligible Age

6 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amira Mahmoud Abd-elmonem

principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eman I Elhadidy

Role: STUDY_CHAIR

Cairo University

Maya G Abd elwahab

Role: STUDY_DIRECTOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy

Giza, , Egypt

Site Status

Faculty of Physical Therapy

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Somaya E Sherif

Role: CONTACT

01062661942

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Somaya E Sherif

Role: primary

01062661942

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VRapeutic software

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.